Document:

Exhibit
10.28

    

    (Summary
English Translations)

    

    Exclusive
Distribution Agreements

    

    
      	
               
      

            	
              (1)

            	
              Party
      A: Shandong Donge Ejiao Co., Ltd.
(“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: December 17, 2009

    Pursuant
to the Agreement, the Company will purchase Ejiao from the Supplier and
distribute the product in Jilin Province.  The parties agreed on a minimum
quantity of the product in the Company’s inventory. The Company must guarantee
that it will purchase the product from the Supplier in three days whenever its
inventory falls below the minimum quantity. The Company is entitled to
commission of 3% of the total sales.  

    

    
      	
               
      

            	
              (2)

            	
              Party
      A: Xiamen Hongren Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: January 10, 2010

    Pursuant
to the Agreement, the Company will purchase Wuji Baifeng Pills from the Supplier
and distribute the product in Jilin Province. The parties agreed that the
purchase price of the product is 7.5 RMB/bottle, the retail price is 9.7
RMB/bottle. The Company must sell the product at the agreed price and must not
sell the product outside Jilin Province. The Company must purchase a minimum
quantity of 20 units of the product in inventory for every three months. The
Company is entitled to commission of 4% of the total sales.  

    

    
      	
               
      

            	
              (3)

            	
              Party
      A: Shandong Shenzhou Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: January 4, 2010

    Pursuant
to the Agreement, the Company will purchase Kangfuyan Capsules from the Supplier
and distribute the product in Jilin Province.  The parties agreed that the
purchase price of the product is 32 RMB/box and the Company will distribute a
total amount of 300,000 RMB of the product during the contract term. If the
Company fails to distribute such amount, its year-end bonus will be deducted by
0.3%. The Company is entitled to commission of 0.3% to 3% of the total sales.
 

    

    
      	
               
      

            	
              (4)

            	
              Party
      A: Guangzhou Qixing Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date:  February 5, 2010

    Pursuant
to the Agreement, the Company will purchase 11 types of pharmaceutical products
from the Manufacture and distribute the products in Jilin Province. The parties
agreed that the Company will distribute a total amount of 600,000 RMB of the
products during the contract term. The contract term is from December 1, 2009 to
December 20, 2010. The Company is entitled to commission of 0.5% to 2.5% of the
total sales.  

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	
               
      

            	
              (5)

            	
              Party
      A: Dezhou Deyao Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: January 4, 2010

    Pursuant
to the Agreement, the Company will purchase Degaoning and Fendining from the
Supplier and distribute the products in Jilin Province. The parties agreed that
the Company will purchase Degaoning and Fendining at 15 RMB/box and 12 RMB/box
respectively and distribute a total amount of 200,000 RMB of the products during
the contract term. The Company is entitled to commission of 0.3% to 3% of the
total sales.  

    

    
      	
               
      

            	
              (6)

            	
              Party
      A: Kunming Pharmaceutical Group Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: March 27, 2010

    Pursuant
to the Agreement, the Company will purchase Xuesaitong Injection from the
Supplier and distribute the product in Jilin Province. The parties agreed that
the Company will purchase the product at 8.5 RMB/box and distribute a total
amount of 300,000 RMB of the product during the contract term. The Company is
entitled to commission of 1% to 3% of the total sales.  

    

    
      	
               
      

            	
              (7)

            	
              Party
      A: Yangzijiang Pharmaceutical Group
(“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: March 24, 2010

    Pursuant
to the Agreement, the Company will purchase a certain products from the Supplier
and distribute the products in Jilin Province. The parties agreed that the
Company will purchase and distribute a total amount of 700,000 RMB of the
products during the contract term. (no commission is stated in the
agreement).

    

    
      	
               
      

            	
              (8)

            	
              Party
      A: Jiangxi Jiangzhong Pharmaceutical Trade Co., Ltd.
      (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: January 4, 2010

    Pursuant
to the Agreement, the Company will purchase 3 types of products from the
Supplier and distribute the products in Jilin Province. The contract term is
from January 4, 2010 to December 31, 2010. The Company is entitled to commission
of 3% to 5.5% of the total sales.

    

    
      	
               
      

            	
              (9)

            	
              Party
      A: Shandong Wohua Pharmaceutical Technology Co., Ltd.
      (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Party A
signed on March 10, 2010; Party B signed on February 23, 2010.

    Pursuant
to the Agreement, the Company will purchase Xinkeshu Pills from the Supplier and
distribute the product in Jilin Province. The parties agreed that the Company
will purchase and distribute a total amount of 200,000 RMB of the product during
the contract term. The Company is entitled to commission of 1% to 3% of the
total sales.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      	
               
      

            	
              (10)

            	
              Party
      A: Hainan Bikai Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: N/A

    Pursuant
to the Agreement, the Company will purchase and distribute 14 types of products
from the Supplier. The Company is entitled to 2% of the total
sales.

     

    
      	
               
      

            	
              (11)

            	
              Party
      A: Zhuhai Lianbang Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: February 23, 2010

    Pursuant
to the Agreement, the Company will purchase and distribute a certain types of
products from the Supplier. The parties agreed that the Company will purchase
and distribute a total amount of [UNCLEAR] RMB of the products during the
contract term. The Company is entitled to 1.5% of the total sales.

    

    
      	
               
      

            	
              (12)

            	
              Party
      A: Guizhou Yibai Pharmaceutical Co., Ltd.
  (“Supplier”)

            

    

    Party B:
Changchun Yongxin Dirui Medical Co., Ltd. (“Company”)

    Execution
Date: N/A

    Pursuant
to the Agreement, the Company will purchase all types of over-the-counter drugs
from the Supplier and distribute the products in Jilin Province. The parties
agreed that the Company will purchase and distribute a total amount of 2,000,000
RMB of the products during the contract term. (no commission is stated in the
agreement).Exhibit
10.29

    

    English
Summary Translation

    

    Loan
Agreement

     

    Lender(Party
A): Yongxin Liu

    Borrower
(Party B): Changchun Yongxin Dirui Medical Co., Ltd.

    

    Party A
and Party B hereby enter into the following agreement:

    

    
      	
               
      

            	
              1.

            	
              Loan
      amount: RMB 9,000,000

            

    

    
      	
               
      

            	
              2.

            	
              Term
      of loan: three years, from January 25, 2008 to January 24, 2011. No
      interest.

            

    

    
      	
               
      

            	
              3.

            	
              Party
      B guarantees that Party B will repay the loan within the time period
      prescribed in this Agreement.

            

    

    
      	
               
      

            	
              4.

            	
              If
      Party B fails to repay the loan within the time period prescribed in this
      Agreement, Party A shall have the right to seek repayment according to
      law.

            

    

    
      	
               
      

            	
              5.

            	
              The
      parties may enter into supplemental agreement for any unsettled
      matters.

            

    

    
      	
               
      

            	
              6.

            	
              The
      supplement agreement shall have the same effective as this
      Agreement.

            

    

    
      	
               
      

            	
              7.

            	
              This
      Agreement is executed into two duplicates. Each party shall hold one
      duplicate.

            

    

    

    Lender
(Party A): Yongxin Liu

    Borrower
(Party B): Changchun Yongxin Dirui Medical Co., Ltd.

    

    Date:
January 25, 2008

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]